ZynexZYXI
ZYXI
About: Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Employees: 1,000
0
Funds holding %
of 7,323 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
4% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 25
5.05% less ownership
Funds ownership: 25.12% [Q4 2024] → 20.07% (-5.05%) [Q1 2025]
10% less funds holding
Funds holding: 96 [Q4 2024] → 86 (-10) [Q1 2025]
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
62% less call options, than puts
Call options by funds: $15K | Put options by funds: $39K
78% less capital invested
Capital invested by funds: $64.1M [Q4 2024] → $14.1M (-$50M) [Q1 2025]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$3
20%
upside
Avg. target
$5.50
120%
upside
High target
$8
220%
upside
2 analyst ratings
1 positive
50%
1 neutral
50%
0 negative
0%
RBC Capital Shagun Singh | 20%upside $3 | Sector Perform Maintained | 15 Jul 2025 |
HC Wainwright & Co. Yi Chen | 220%upside $8 | Buy Reiterated | 30 Jun 2025 |
Financial journalist opinion
Based on 7 articles about ZYXI published over the past 30 days
Neutral
PRNewsWire
1 week ago
Zynex Sets Second Quarter 2025 Earnings Call
ENGLEWOOD, Colo. , July 22, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, July 31, 2025 at 4:15 PM Eastern Time to discuss its financial results for the second quarter ended June 30, 2025.
Neutral
Proactive Investors
2 weeks ago
Zynex: New CEO Steven Dyson shares his vision – ICYMI
Zynex Inc (NASDAQ:ZYXI) earlier this week outlined changes to its leadership as Thomas Sandgaard prepares to move into the chairman role. The company said Steven Dyson will step in as the new chief executive officer.
Neutral
GlobeNewsWire
2 weeks ago
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zynex, Inc. (NASDAQ:ZYXI) on behalf of long-term stockholders following a class action complaint that was filed against Zynex on July 9, 2025 with a Class Period from March 13, 2023, to the present. Our investigation concerns whether the board of directors of Zynex have breached their fiduciary duties to the company.
Neutral
Proactive Investors
3 weeks ago
Zynex CEO Thomas Sandgaard discusses leadership transition - ICYMI
Zynex Inc (NASDAQ:ZYXI) CEO Thomas Sandgaard talked with Proactive about his decision to step down from his position after nearly three decades leading the medical device company. He described the challenges of starting a company with no funding, navigating public listings, and expanding operations to help over a million patients manage pain.
Neutral
PRNewsWire
3 weeks ago
Tricare Temporary Payment Suspension Update
ENGLEWOOD, Colo. , July 2, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company received an update from Tricare that the temporary payment suspension will continue.
Neutral
Proactive Investors
4 weeks ago
Zynex taps Steve Dyson as chief executive officer
Zynex Inc (NASDAQ:ZYXI) has announced the appointment of Steve Dyson as chief executive officer, marking a new chapter for the medical technology company founded in 1996 by its outgoing CEO Thomas Sandgaard. Sandgaard will continue to serve as chairman of the board and will also lead the company's Technology Committee.
Neutral
PRNewsWire
4 weeks ago
Zynex Announces Steven Dyson as New CEO
ENGLEWOOD, Colo. , June 30, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of Steven Dyson as Chief Executive Officer.
Positive
Proactive Investors
1 month ago
Zynex awarded UK patent for non-invasive sepsis monitoring technology
Zynex Inc (NASDAQ:ZYXI) announced that it has been issued a UK patent for its multiparameter, non-invasive sepsis monitor. The company highlighted that its patented technology is designed to continuously track multiple physiological signals with the goal of providing early alerts on patient trends and potential sepsis development.
Neutral
PRNewsWire
1 month ago
Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis
ENGLEWOOD, Colo. , June 25, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has been awarded UK patent 2617515 for a multiparameter, noninvasive sepsis monitor.
Neutral
Accesswire
2 months ago
Lost Money on Zynex, Inc. (ZYXI)? Contact Levi & Korsinsky Before May 19, 2025 to Join Class Action
NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zynex-inc-lawsuit-submission-form?prid=149275&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.
Charts implemented using Lightweight Charts™